Karyopharm(KPTI)

7.16 -0.10 -1.3774%

今开:7.28昨收:7.26
最高:7.31 最低:7.0
涨停价:0.0跌停价:0.0
总市值:5.40920086E8

Karyopharm的热门评论

Karyopharm(KPTI)2020-09-25 21:27

$Karyopharm(KPTI)$ 8-K Current report, items 5.02 and 9.01 Accession Number: 0001193125-20-254004 Act: 34 Size: 182 KB 网页链接查看全文

Karyopharm(KPTI)2020-09-10 20:51

$Karyopharm(KPTI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-049920 Size: 8 KB 网页链接查看全文

Karyopharm(KPTI)2020-09-01 06:06

$Karyopharm(KPTI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-048840 Size: 5 KB 网页链接查看全文

Karyopharm(KPTI)2020-09-01 04:42

$Karyopharm(KPTI)$ 8-K Current report, items 5.02 and 9.01 Accession Number: 0001193125-20-236284 Act: 34 Size: 307 KB 网页链接查看全文

Karyopharm(KPTI)2020-09-01 05:51

$Karyopharm(KPTI)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001209191-20-048825 Size: 7 KB 网页链接查看全文

Karyopharm(KPTI)2020-08-28 04:27

$Karyopharm(KPTI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-048515 Size: 4 KB 网页链接查看全文

美股生物医药:本周回顾以及下周展望 (2019.7.05)

淘沙见金2019-07-06 09:13

一顿操作猛如虎,再看收益零点五。 本周由于美国国庆假期,交易日只有短短的3天半,因此本篇回顾和前瞻篇幅会比较短(这个偷懒的理由真是无懈可击)。 先说说人见人爱、花见花开的 Amarin($阿玛琳(AMRN)$)。这周公司上调了2019年Vascepa的销售预期,股价也是应声大涨。哎,小药企的管理层真像抖...查看全文

Karyopharm(KPTI)2020-08-25 18:06

$Karyopharm(KPTI)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001193125-20-228623 Act: 33 Size: 92 KB 网页链接查看全文

美股医药Z博士2019-07-10 01:25

$Karyopharm(KPTI)$ 基本上很接近批准前的高点6.6左右了,公司现金也还行。可能短期增发,但是非常的undervalue。建议搞点,ER的销售预期(计划)可能是个近期的催化剂,年底还有BOSTON TRIAL的催化剂。估计做个短线的波段,涨到9-10块左右压力不大。查看全文

Karyopharm(KPTI)2020-08-19 08:43

$Karyopharm(KPTI)$ 内部交易: 2020-08-17,CEO,Kauffman Michael ,期权,1477普通股, $0.03查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50

Karyopharm的公告

当期报告

$Karyopharm(KPTI)$ 8-K Current report, item 7.01 Accession Number: 0001193125-21-350809 Act: 34 Size: 144 KB 网页链接

首次持股声明

$Karyopharm(KPTI)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001209191-21-068260 Size: 7 KB 网页链接

持股变动声明

$Karyopharm(KPTI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-21-068261 Size: 5 KB 网页链接

当期报告

$Karyopharm(KPTI)$ 8-K Current report, item 5.02 Accession Number: 0001193125-21-349022 Act: 34 Size: 147 KB 网页链接

$Karyopharm(KPTI)$ 内部交易: 2021-12-02,SVP, Chief Business Officer,Mitchener Stephen ,卖出,499普通股, $6.69

持股变动声明

$Karyopharm(KPTI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-21-067954 Size: 5 KB 网页链接

季度财报

$Karyopharm(KPTI)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-21-002729 Act: 34 Size: 9 MB 网页链接

当期报告

$Karyopharm(KPTI)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001193125-21-317648 Act: 34 Size: 274 KB 网页链接

超过5%股东持股披露「修订」

$Karyopharm(KPTI)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000093751-21-000679 Act: 34 Size: 10 KB 网页链接

员工持股计划

$Karyopharm(KPTI)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001193125-21-237892 Act: 33 Size: 93 KB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78